Karine Scherzinger-Laude

Angiopoietin-2 inhibition using siRNA or the peptide antagonist L1–10 results in antitumor activity in human neuroblastoma

Saritha S. D’souza, J. Rössler, B. Salimath, 2012, Journal of Cancer Research and Clinical Oncology.

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)

J. Rössler, R. Süss, Felicitas Lewrick, 2013, International journal of nanomedicine.